Introduction: For patients (pts) with AML, a complete remission (CR) prior to allogeneic
hematopoietic cell transplantation (alloHCT) is a favourable risk factor. However, whether pts with …

Several studies suggest that harnessing natural killer (NK) cell reactivity mediated through
killer cell immunoglobulin-like receptors (KIRs) could reduce the risk of relapse after …

Background The SARS‐CoV‐2 pandemic has strained health systems worldwide, and
infection numbers continue to rise. While previous data have already shown that many patients …

HLA molecules are key restrictive elements to present intracellular antigens at the crossroads
of an effective T-cell response against SARS-CoV-2. To determine the impact of the HLA …

Objectives To determine the impact of the 32 bp deletion (CCR5Δ32) in the coding region of
the CC chemokine receptor 5 (CCR5) on the risk of contracting SARS-CoV-2 and severe …

Optimizing natural killer (NK) cell alloreactivity could further improve outcome after allogeneic
hematopoietic cell transplantation (alloHCT). The donor’s Killer-cell Immunoglobulin-like …

With the continuous increase in the use of haploidentical donors for transplantation, the
selection of donors becomes increasingly important. Haploidentical donors have been selected …

Results from registry studies suggest that harnessing Natural Killer (NK) cell reactivity mediated
through Killer cell Immunoglobulin-like Receptors (KIR) could reduce the risk of relapse …

Background Whether high-dose cytarabine-based salvage chemotherapy, administered to
induce complete remission in patients with poor responsive or relapsed acute myeloid …

In acute myeloid leukemia (AML), donor natural killer cell killer immunoglobulin–like receptors
(KIR) and recipient HLA interactions may contribute to the graft-versus-leukemia effect of …